NeuroMetrix Showcases Quell Technology At SLEEP 2016, The 30th Anniversary Meeting Of The Associated Professional Sleep Societies

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell^® Wearable Pain Relief Technology^™ will be featured at SLEEP 2016, which is a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. The meeting takes place June 11-15 in Denver, CO.

“Impact of Transcutaneous Electrical Nerve Stimulation (TENS) Therapy on Sleep Efficiency in Subjects with Chronic Pain.”

There are over 100 million Americans with chronic pain. According to the American Academy of Pain Medicine, 86% of people with chronic pain report an inability to sleep well. Quell utilizes neurostimulation technology to provide relief from chronic pain. The wearable device is lightweight and can be worn during the day while active, and at night while sleeping. Quell objectively tracks utilization and various health metrics including sleep. In a recent study of Quell, 81% of participants reported improvement in their chronic pain on the Patient Global Impression of Change (PGIC) scale. In addition, participants reported a statistically and clinically significant reduction in pain interference with sleep. Please visit www.QuellRelief.com to learn more about Quell.

“We are pleased to take part in SLEEP 2016 and will share the role that Quell’s innovative technology can play in improving sleep for chronic pain sufferers,” said Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix.

Two scientific posters on Quell technology will be presented.

• “Impact of Transcutaneous Electrical Nerve Stimulation (TENS) Therapy on Sleep Efficiency in Subjects with Chronic Pain.” Sunday June 12 from 5:00 PM - 7:00 PM.
• “Pilot Open-label Trial Of Transcutaneous Electrical Nerve Stimulation (TENS) Below The Knee For The Treatment Of Restless Legs Syndrome (RLS).” Monday June 13 from 4:00 PM - 6:00 PM.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.